Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Testosterone undecanoate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Nebido 1000mg/4ml solution for injection vials
0604020T0BDABAD
|
Nebido | Testosterone undecanoate | Endocrine System | 37,495 |
|
Testosterone undecanoate 1g/4ml solution for injection vials
0604020T0AAADAD
|
Testosterone undecanoate | Testosterone undecanoate | Endocrine System | 12,473 |
|
Testosterone 40mg capsules
0604020T0AAAAAA
|
Testosterone undecanoate | Testosterone undecanoate | Endocrine System | 108 |
|
Restandol 40mg Testocaps
0604020T0BBABAA
|
Restandol | Testosterone undecanoate | Endocrine System | 37 |
|
Nebido 1000mg/4ml solution for injection ampoules
0604020T0BDAAAC
|
Nebido | Testosterone undecanoate | Endocrine System | 22 |
|
Testosterone undecanoate 1g/4ml inj ampoules
0604020T0AAACAC
|
Testosterone undecanoate | Testosterone undecanoate | Endocrine System | 1 |
|
Restandol 40mg capsules
0604020T0BBAAAA
|
Restandol | Testosterone undecanoate | Endocrine System | No data available |
|
Roxadin 1000mg/4ml solution for injection vials
0604020T0BEAAAD
|
Roxadin | Testosterone undecanoate | Endocrine System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.